Jim Cramer: Newly public Royalty Pharma is a great way to play biotech
"I think the story is so compelling that it's worth putting on a small position even up here," the "Mad Money" host said.
For access to live and exclusive video from CNBC subscribe to CNBC PRO:
https://cnb.cx/2JdMwO7
» Subscribe to CNBC TV: https://cnb.cx/SubscribeCNBCtelevision
» Subscribe to CNBC: https://cnb.cx/SubscribeCNBC
» Subscribe to CNBC Classic: https://cnb.cx/SubscribeCNBCclassic
Turn to CNBC TV for the latest stock market news and analysis. From market futures to live price updates CNBC is the leader in business news worldwide.
Connect with CNBC News Online
Get the latest news: http://www.cnbc.com/
Follow CNBC on LinkedIn: https://cnb.cx/LinkedInCNBC
Follow CNBC News on Facebook: https://cnb.cx/LikeCNBC
Follow CNBC News on Twitter: https://cnb.cx/FollowCNBC
Follow CNBC News on Instagram: https://cnb.cx/InstagramCNBC
#CNBC
#CNBC TV
Видео Jim Cramer: Newly public Royalty Pharma is a great way to play biotech канала CNBC Television
For access to live and exclusive video from CNBC subscribe to CNBC PRO:
https://cnb.cx/2JdMwO7
» Subscribe to CNBC TV: https://cnb.cx/SubscribeCNBCtelevision
» Subscribe to CNBC: https://cnb.cx/SubscribeCNBC
» Subscribe to CNBC Classic: https://cnb.cx/SubscribeCNBCclassic
Turn to CNBC TV for the latest stock market news and analysis. From market futures to live price updates CNBC is the leader in business news worldwide.
Connect with CNBC News Online
Get the latest news: http://www.cnbc.com/
Follow CNBC on LinkedIn: https://cnb.cx/LinkedInCNBC
Follow CNBC News on Facebook: https://cnb.cx/LikeCNBC
Follow CNBC News on Twitter: https://cnb.cx/FollowCNBC
Follow CNBC News on Instagram: https://cnb.cx/InstagramCNBC
#CNBC
#CNBC TV
Видео Jim Cramer: Newly public Royalty Pharma is a great way to play biotech канала CNBC Television
Показать
Комментарии отсутствуют
Информация о видео
Другие видео канала
Nike's challenges are quite similar to what we're seeing at Starbucks, says Peter AtwaterFinal Trades: Leidos Holdings, Western Union and WalmartBreaking down shares of Hilton, Expedia and Match GroupJanus Henderson’s Nick Cherney on tokenizing a fund instead of going the ETF routeLong-term interest rates could rise despite the Fed's cut, says Greenwich Wealth's Vahan JanjigianThree Buys and a Bail: Nike, Boeing, Starbucks, and 3M3-Stock Lunch: Meta, General Motors, & Keurig Dr PepperBig Tech investments represent a 'paradigm shift' in energy demand, says Uranium Energy Corp CEOThree-Stock Lunch: S&P Homebuilders Index, Nvidia & JPMorganFinal Trades: Samsara, Constellation Energy, Aptiv and the INDY‘Customers want value': TD Cowen's Chen sees global challenges for luxury retailNike's CEO change is encouraging, but the recovery may take longer than anticipated, says JPM's BossMitrione: The market is really happy with lower rates. Tech benefits a lot from them.Widlitz: It's great news they're bringing back somebody with a 32-year track record at Nike.Powell: We're not discarding any piece of economic dataAlaska Airlines CEO on Hawaiian merger: It's pro-consumer and pro-competitionOpening Bell, December 15, 2022ETF Edge, September 23, 2024Supreme Court to hear Coinbase user arbitration disputeOpening Bell: September 23, 2024Qualcomm acquiring Intel is a pipe dream: Mizuho Americas' Jordan Klein